Spleen Stiffness Measurement as a Predictor of Advanced Liver Fibrosis in Chronic Hepatitis B Patients

Carisa Irene Hertanto(1), Ummi Maimunah(2), Aryati -(3), Muhammad Miftahussurur(4),


(1) Undergraduate Student, Medical Faculty of Universitas Airlangga, Surabaya, Indonesia
(2) Gastroenterology and Hepatology Division, Department of Internal Medicine, Medical Faculty of Universitas Airlangga – Dr. Soetomo Hospital, Surabaya, Indonesia
(3) Clinical Pathology Department, Medical Faculty of Universitas Airlangga – Dr. Soetomo Hospital, Surabaya, Indonesia
(4) Gastroenterology and Hepatology Division, Department of Internal Medicine, Medical Faculty of Universitas Airlangga – Dr. Soetomo Hospital, Surabaya, Indonesia / Helicobacter pylori and Microbiota Study Group, Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia
Corresponding Author

Abstract


Background: Chronic hepatitis B is a viral infection that may progress to liver fibrosis. Progressive fibrosis increases portal pressure, leading to elevated spleen stiffness. Although inflammatory reactions and mechanical cholestasis affect liver stiffness, the effect is comparatively limited. Therefore, this study aims to analyze spleen stiffness as a noninvasive marker of liver fibrosis and evaluate the correlation between spleen and liver stiffness.

Methods: A retrospective cross-sectional study was performed on chronic hepatitis B patients. Fibroscan was used to measure liver and spleen stiffness. Liver fibrosis was categorized as nonsignificant (F0–F1), significant (F2–F3), and advanced (F4). Correlations between spleen stiffness and liver fibrosis stages were assessed using Spearman’s test, with p < 0.05 considered statistically significant.

Results: The results showed that 127 patients were eligible for analysis, predominantly male (71.7%), with a mean age of 46.4 ± 9.8 years. The median spleen and liver stiffness were 25.5 kPa (range 5.6–100) and 9.4 kPa (range 2.4–75), respectively. Moreover, spleen stiffness had a positive correlation with liver stiffness (Spearman r = 0.503; p < 0.001) and liver fibrosis stages (Spearman r = 0.479; p < 0.001). The optimal cutoff for spleen stiffness in predicting advanced fibrosis was 28 kPa, with an area under the receiver operating characteristic curve(AUROC) of 0.816, sensitivity of 0.739, and specificity of 0.753.

Conclusion: Spleen stiffness is significantly correlated with liver fibrosis severity. A cutoff of 28 kPa was identified for advanced fibrosis, suggesting spleen stiffness measurement serves as a promising alternative to biopsy.


Keywords


Chronic Hepatitis B, Fibroscan, Liver Fibrosis, Liver Stiffness, Spleen Stiffness

References


Zhou K, Dodge JL, Grab J, Poltavskiy E, Terrault NA. Mortality in adults with chronic hepatitis B infection in the United States: a population-based study. Aliment Pharmacol Ther. 2020;52(2):382–389.

World Health Organization. Hepatitis B [Internet]. Geneva: World Health Organization; 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b

Dwiartama A, Nirbayati WF, Giri-Rachman EA, Niloperbowo W, Tan MI, Anin A. Knowledge, attitude, and practice towards hepatitis B infection prevention and screening among Indonesians. Int J Environ Res Public Health. 2022;19(8):4644.

Lee MJ. A review of liver fibrosis and cirrhosis regression. J Pathol Transl Med. 2023;57(4):189–195.

Chowdhury AB, Mehta KJ. Liver biopsy for assessment of chronic liver diseases: a synopsis. Clin Exp Med. 2023;23:1–10.

Losurdo G, Ditonno I, Novielli D, Celiberto F, Iannone A, Castellaneta A, et al. Comparison of transient elastography and point shear wave elastography for analysis of liver stiffness: a prospective study. Diagnostics (Basel). 2024;14(6):604.

Lee HA. Liver fibrosis assessment in chronic liver diseases using elastography: a comprehensive review of vibration-controlled transient elastography and shear wave elastography. Clin Ultrasound. 2024;9(2):70–84.

Lantinga MA, van Kleef LA, den Hoed CM, de Knegt RJ. Spleen stiffness measurement across the spectrum of liver disease patients in real-world practice. J Clin Exp Hepatol. 2023;13(3):414–427.

Mendoza Y, Rodrigues S, Delgado MG, Murgia G, Lange N, Schropp J, et al. Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two-dimensional shear wave elastography in non-alcoholic fatty liver disease. Liver Int. 2022;42(1):102–111.

Sugio R, Sawai Y, Fukuda K, Igura T, Kogita S, Ichihi M, et al. Changes in liver and splenic stiffness after direct-acting antiviral therapy in chronic hepatitis C: a single-centre prospective observational study. GastroHep. 2022;2022:1–8.

Lee YK, Lee DH, Joo SK, Jang H, So YH, Jang S, et al. Combi-elastography versus transient elastography for assessing the histological severity of metabolic dysfunction-associated steatotic liver disease. Gut Liver. 2024;18(6):1048–1059.

Hu X, Xu X, Zhang Q, Zhang H, Liu J, Qian L. Indirect prediction of liver fibrosis by quantitative measurement of spleen stiffness using the FibroScan system. J Ultrasound Med. 2014;33(1):73–81.

Yang LB, Gao X, Xu M, Li Y, Dong L, Huang XD, et al. Noninvasive model based on liver and spleen stiffness for predicting clinical decompensation in patients with cirrhosis. World J Gastroenterol. 2025;31(33):1–12.

Zheng Y, Xia S, Ren X, Zhan W, Zheng Z, Chen Z. A study of spleen shear-wave elastography in indirect prediction of liver fibrosis in patients with chronic hepatitis B. Clin Hemorheol Microcirc. 2020;76(1):63–72.

Cheng YW, Chang YC, Chen YL, Chen RC, Chou CT. Feasibility of measuring spleen stiffness with MR elastography and splenic volume to predict hepatic fibrosis stage. PLoS One. 2019;14(5):e0217876.

Arya S, Dixit R, Harish CS, Prakash A, Puri AS. Our experience with liver and spleen elastography in the prediction of oesophageal varices. S Afr J Radiol. 2024;28(1):1–8.

Mossie GY, Nur AM, Ayalew ZS, Azibte GT, Berhane KA. Platelet counts to spleen diameter ratio: a promising noninvasive tool for predicting esophageal varices in cirrhosis patients. World J Hepatol. 2024;16(10):1177–1187.

Colecchia A, Colli A, Casazza G, Mandolesi D, Schiumerini R, Reggiani LB, et al. Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study. J Hepatol. 2014;60(6):1158–1164.

Chen SH, Li YF, Lai HC, Kao JT, Peng CY, Chuang PH, et al. Noninvasive assessment of liver fibrosis via spleen stiffness measurement using acoustic radiation force impulse sonoelastography in patients with chronic hepatitis B or C. J Viral Hepat. 2012;19(9):654–663.


Full Text: PDF

Article Metrics

Abstract View : 100 times
PDF Download : 20 times

DOI: 10.24871/2632025237-244

Refbacks

  • There are currently no refbacks.